| Shigama K, Nakaya A, Wakame K, et al.
Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice. [Journal Article]
J Exp Ther Oncol 2009; 8(1):43-51.
Abstract | Full Citation | | Nelson BH
IDO and outcomes in ovarian cancer. [Editorial]
Gynecol Oncol 2009 Nov; 115(2):179-80.
Full Citation | Find Related Articles | | Koizumi W, Akiya T, Sato A, et al.
Second-line Chemotherapy with Biweekly Paclitaxel after Failure of Fluoropyrimidine-based Treatment in Patients with Advanced or Recurrent Gastric Cancer: a Report from the Gastrointestinal Oncology Group of the Tokyo Cooperative Oncology Group, TCOG GC-0501 Trial. [JOURNAL ARTICLE]
Jpn J Clin Oncol 2009 Oct 6.
Abstract | Full Citation | Find Related Articles | | Huang HC, Shi J, Orth JD, et al.
Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly. [Journal Article, Research Support, N.I.H., Extramural]
Cancer Cell 2009 Oct 6; 16(4):347-58.
Abstract | Full Citation | | Xiang F, Yu J, Yin R, et al.
Structure-activity relationship of taxol inferring from docking taxol analogues to microtubule binding site. [Journal Article, Research Support, Non-U.S. Gov't]
Z Naturforsch C 2009 Jul-Aug; 64(7-8):551-6.
Abstract | Full Citation | Find Related Articles | | Silber S, Colombo A, Banning AP, et al.
Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions. [Journal Article, Research Support, Non-U.S. Gov't]
Circulation 2009 Oct 13; 120(15):1498-504.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Nikolsky E, Lansky AJ, Sudhir K, et al.
SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease. [Clinical Trial, Phase IV, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial]
Am Heart J 2009 Oct; 158(4):520-526.e2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Di Lorenzo E, Sauro R, Varricchio A, et al.
Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial. [Comparative Study, Journal Article, Randomized Controlled Trial]
Am Heart J 2009 Oct; 158(4):e43-50.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Mohammadi A, Esmaeili F, Dinarvand R, et al.
Development and validation of a stability-indicating method for the quantitation of Paclitaxel in pharmaceutical dosage forms. [Journal Article, Research Support, Non-U.S. Gov't]
J Chromatogr Sci 2009 Aug; 47(7):599-604.
Abstract | Full Citation | Find Related Articles | | Innocente F, Mandracchia D, Pektok E, et al.
Paclitaxel-eluting biodegradable synthetic vascular prostheses: a step towards reduction of neointima formation? [Journal Article, Research Support, Non-U.S. Gov't]
Circulation 2009 Sep 15; 120(11 Suppl):S37-45.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
